Segall Bryant & Hamill International Equity Ins (CIEQX)
14.31
-0.19
(-1.31%)
USD |
Mar 18 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.84% | 13.85M | 3.37% | 111.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 8.560M | 27.88% |
Basic Info
| Investment Strategy | |
| The Fund seeks to achieve long-term capital appreciation. It will invest at least 80% of its net assets in equity securities, primarily common stock, of companies located outside of the United States. The Adviser uses proprietary quantitative models to evaluate and select countries and securities for the Fund's portfolio. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Segall Bryant & Hamill |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
52
-1.713B
Peer Group Low
2.358B
Peer Group High
1 Year
% Rank:
37
8.560M
-2.759B
Peer Group Low
19.50B
Peer Group High
3 Months
% Rank:
44
-1.015B
Peer Group Low
8.232B
Peer Group High
3 Years
% Rank:
35
-7.699B
Peer Group Low
38.87B
Peer Group High
6 Months
% Rank:
43
-1.487B
Peer Group Low
14.02B
Peer Group High
5 Years
% Rank:
36
-14.47B
Peer Group Low
63.91B
Peer Group High
YTD
% Rank:
47
-2.175B
Peer Group Low
4.133B
Peer Group High
10 Years
% Rank:
48
-44.44B
Peer Group Low
118.12B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 19, 2026.
Asset Allocation
As of January 31, 2026.
| Type | % Net |
|---|---|
| Cash | 0.00% |
| Stock | 99.18% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.23% |
| Other | 0.59% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Novartis AG | 2.28% | 150.19 | -0.44% |
| Roche Holding AG (DELISTED) | 2.07% | 432.80 | 7.42% |
| ASML Holding NV | 1.69% | 1347.36 | -0.20% |
| Banco Bilbao Vizcaya Argentaria SA | 1.68% | 20.66 | -1.53% |
| BNP Paribas SA | 1.54% | 96.21 | -0.43% |
| GSK Plc | 1.50% | 26.88 | 0.00% |
| NatWest Group Plc | 1.47% | 7.10 | -8.86% |
| Deutsche Bank AG | 1.36% | 28.92 | -1.06% |
| ITOCHU Corp. | 1.30% | 13.16 | 2.41% |
| Danske Bank A/S | 1.22% | 54.48 | 0.00% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | 16.36K% |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 250000.0 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks to achieve long-term capital appreciation. It will invest at least 80% of its net assets in equity securities, primarily common stock, of companies located outside of the United States. The Adviser uses proprietary quantitative models to evaluate and select countries and securities for the Fund's portfolio. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Multi-Cap Core |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | Segall Bryant & Hamill |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (3-17-26) | 1.52% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 349 |
| Stock | |
| Weighted Average PE Ratio | 17.08 |
| Weighted Average Price to Sales Ratio | 1.866 |
| Weighted Average Price to Book Ratio | 2.753 |
| Weighted Median ROE | 28.60% |
| Weighted Median ROA | 5.10% |
| ROI (TTM) | 10.33% |
| Return on Investment (TTM) | 10.33% |
| Earning Yield | 0.0774 |
| LT Debt / Shareholders Equity | 0.9375 |
| Number of Equity Holdings | 347 |
As of January 31, 2026
Growth Metrics
| EPS Growth (1Y) | 17.62% |
| EPS Growth (3Y) | 10.06% |
| EPS Growth (5Y) | 14.27% |
| Sales Growth (1Y) | 3.93% |
| Sales Growth (3Y) | 7.97% |
| Sales Growth (5Y) | 5.66% |
| Sales per Share Growth (1Y) | 5.56% |
| Sales per Share Growth (3Y) | 8.85% |
| Operating Cash Flow - Growth Rate (3Y) | 8.16% |
As of January 31, 2026
Fund Details
| Key Dates | |
| Inception Date | 10/27/2021 |
| Share Classes | |
| CIQRX | Retail |
| Attributes | |
| Inverse Fund | No |
| Leveraged Fund | -- |
| Currency Hedged Fund | -- |
| Socially Responsible Fund |
|
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:CIEQX", "name") |
| Broad Asset Class: =YCI("M:CIEQX", "broad_asset_class") |
| Broad Category: =YCI("M:CIEQX", "broad_category_group") |
| Prospectus Objective: =YCI("M:CIEQX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |